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Objectives: To quantitatively compare the antibiotic susceptibility of biofilms formed by the coagulase-
negative staphylococci (CoNS) Staphylococcus epidermidis and Staphylococcus haemolyticus with the
susceptibility of planktonic cultures.
Methods: SeveralCoNSstrainsweregrownplanktonicallyor asbiofilms todetermine theeffect of themode
of growth on the level of susceptibility to antibiotics with different mechanisms of action. The utility of a
new, rapid colorimetric method that is based on the reduction of a tetrazolium salt (XTT) to measure cell
viability was tested by comparison with standard bacterial enumeration techniques. A 6 h kinetic study
was performed using dicloxacillin, cefazolin, vancomycin, tetracycline and rifampicin at the peak serum
concentration of each antibiotic.
Results: In planktonic cells, inhibitors of cell wall synthesiswere highly effective over a 3hperiod. Biofilms
were much less susceptible than planktonic cultures to all antibiotics tested, particularly inhibitors of cell
wall synthesis. The susceptibility to inhibitors of protein and RNA synthesis was affected by the biofilm
phenotype to a lesser degree. Standard bacterial enumeration techniques and the XTT method produced
equivalent results both in biofilms and planktonic assays.
Conclusions: This study provides a more accurate comparison between the antibiotic susceptibilities of
planktonic versus biofilm populations, because the cell densities in the two populations were similar and
because we measured the concentration required to inhibit bacterial metabolism rather than to eradicate
the entire bacterial population.While the biofilm phenotype is highly resistant to antibiotics that target cell
wall synthesis, it is fairly susceptible to antibiotics that target RNA and protein synthesis.
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Introduction
Staphylococcus epidermidis and related coagulase-negative
staphylococci (CoNS) are now well established as major nosoco-
mial pathogens associated with infections of indwelling medical
devices. Biofilm formation is one of the major virulence factors of
these organisms,1 often leading to persistent infections.2
The fact that biofilm bacteria are able to tolerate significantly
higher levels of antibiotics than planktonic bacteria has been well
established in susceptibility assays, and the clinical relevance of
this phenomenon is underscored by the occurrence of medical
device-related infections that are refractory to antibiotic therapy.3,4
Despite concerted efforts to treat biofilm infections with antibiotic
therapy, the physical removal of an infected medical device is often
necessary,5 which carries an additional economic and health cost.
The resistance of bacterial cells in a biofilm to antibiotics does
not seem to depend on traditional mechanisms of antibiotic resist-
ance.6,7 Although it is not yet clear how biofilms resist anti-
microbial agents, a possible explanation has been suggested by
several authors who assume that biofilms present a diffusional
.............................................................................................................................................................................................................................................................................................................................................................................................................................
*Corresponding author. Tel: +351-253-604-400; Fax: +351-253-678-986; E-mail: jazeredo@deb.uminho.pt
.............................................................................................................................................................................................................................................................................................................................................................................................................................
331
 The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
For Permissions, please e-mail: journals.permissions@oupjournals.org
barrier to antibiotics.8–10 However, it seems that this mechanism
can only partially explain the increased resistance phenotype gen-
erally present in clinically relevant biofilms.11 Other mechanisms
have been suggested, including slow growth of the cells within the
biofilm,12 activation of the general stress response,13 emergence of
a biofilm-specific phenotype14 and persister cells.15 Resistance is
reportedly up to 1000-fold greater in bacterial cells in biofilms,
but a reliable method to compare the antibiotic susceptibilities of
planktonic bacteria with cells in biofilms is lacking.16
The goal of this study was to compare the antibiotic suscept-
ibilities of planktonic versus biofilm bacterial cells, using an
adequate and reliable methodology. We evaluated the resistance
of CoNS cells in biofilms to antibiotics with different molecular
weights and different mechanisms of action: inhibitors of cell wall
synthesis (cefazolin, vancomycin and dicloxacillin), inhibitors of
protein synthesis (tetracycline) and inhibitors of RNA synthesis
(rifampicin). We also compared the susceptibility of CoNS bio-
films with that of planktonic cells, using the classic cfu plating
assay and also a new rapid colorimetric method that measures
cellular metabolic activity, based on the reduction of tetrazolium
salt (XTT), in an attempt to correlate viability assays and activity
assays with the effects of specific antibiotics on cells present in
biofilms.
Material and methods
Antibiotics
The antibiotics and respective concentrations used in this study were
cefazolin 63 mg/L, vancomycin 40 mg/L, dicloxacillin 59 mg/L, tetra-
cycline 16 mg/L and rifampicin 10 mg/L. The main characteristics of
these antibiotics are described in Table 1. The antibiotic concentration
used in all assays was the peak concentration in human serum (PS).
Bacterial strains and growth conditions
A total of six CoNS biofilm-producing strains were used in this
study: S. epidermidis 9142, S. epidermidis IE186, S. epidermidisM129,
S. epidermidis M18717,18 and Staphylococcus haemolyticus IE246,
S. haemolyticus M176.19 Tryptic soy broth (TSB) and tryptic soy
agar (TSA) were prepared according to the manufacturer’s instruc-
tions. All strains were incubated in 15 mL of TSB inoculated with
bacterial cultures <2 days old and grown on TSA plates, for 24 (–2) h at
37C in a shaker rotator at 130 rpm. Cells were harvested by centri-
fugation (for 5 min at 10 500g and 4C), and resuspended in a saline
solution (0.9% NaCl prepared in distilled water) adjusted to an optical
density (620 nm) equivalent to 1 · 109 cells/mL, and then used in the
subsequent assays. MICs were determined according to NCCLS stand-
ards, with some minor modifications, using TSB as a growth medium,
with at least three replicates for each determination (Table 2).
Biofilm formation
Biofilms were produced as described previously.18 Briefly, for each
strain, 10 mL of a cell suspension adjusted to 1 · 109 cells/mL in 0.9%
NaCl was added to a 96-well microtitre plate containing 240 mL of
TSB supplemented with 0.25% of glucose per well to promote biofilm
formation. Plates were incubated at 37C with shaking at 150 rpm,
for 24 (–4) h. The planktonic cells were removed carefully, and the
biofilm was washed twice with 200 mL of 0.9% NaCl. This procedure
yielded a biofilm containing 2 · 108 cells/mL. This was determined
as previously described20 by disrupting the biofilm and resuspending
the cells in TSB + 0.05% Tween, followed by 20 s of sonication at
20 W to homogenize the suspension. This procedure disrupted the cell
clumps without impairing cell viability.20 This was determined by
comparing sonicated and non-sonicated suspensions by Gram staining
and cell viability tests.
Serial dilutions were made and plated on TSA plates that were
incubated overnight at 37C.
Antibiotic susceptibility of planktonic cultures
assessed by cfu plating
For each strain, 200mL of a cell suspension adjusted to 1 · 109 cells/mL
in 0.9% NaCl was added to 30 mL of TSB, and incubated at 37C with
shaking at 130 rpm, until a cell density of 1 · 109 cells/mLwas reached.
Then, a fivefold dilution was made in TSB containing each antibiotic
at the respective PS concentration in order to obtain a cell suspension
of 2 · 108 cells/mL, and growth was allowed to occur over 6 h. A
control was obtained by diluting the suspension in fresh TSB without
adding antibiotic. Each hour a 1 mL sample was collected and cent-
rifuged for 8 min at 9000g, and the pellet resuspended in 0.9% NaCl.
Two washing steps were performed, followed by 20 s of sonication
at 20 W. The viable cells were determined by performing 10-fold
serial dilutions of this suspension, which were plated on TSA plates
that were then incubated for 20 h at 37C. This experiment was
repeated three times, in triplicate.
Antibiotic susceptibility of biofilms assessed
by cfu plating
Biofilms were prepared in 96-well microtitre plates, as described
above, yielding an initial cell concentration of about 2 · 108 cells/mL.
To eachwell containing the biofilm, 200mL of TSB supplemented with
0.25% of glucose and one of the antibiotics at the PS concentration
Table 1. Characteristics of the antibiotics used in this study
Antibiotic Mechanism of actiona PSb MWa
Cefazolin Cell wall synthesis inhibitor 63 477
Vancomycin Cell wall synthesis inhibitor 40 1485
Dicloxacillin Cell wall synthesis inhibitor 59 481
Tetracycline Protein synthesis inhibitor 16 823
Rifampicin RNA synthesis inhibitor 10 492
aThe mechanism of action and the molecular weight (MW) in g/mol of the
antibiotics were provided by the manufacturer.
bThe peak serum concentrations (PS) in mg/L of cefazolin, vancomycin,
tetracycline and rifampicin were obtained according to NCCLS28 and for
dicloxacillin according to Friberg et al.38
Table 2. Determination of the MIC ranges in mg/L for six
coagulase-negative staphylococci and five antibiotics
Strain CFZ VAN DCX TET RIF
S. epidermidis 9142 64–128 8–16 64–128 0.5–2 0.03–0.12
S. epidermidis IE186 2–16 8 0.5–4 2–4 0.03–0.06
S. epidermidis M129 4–32 8 4–16 16–32 0.03–0.06
S. epidermidis M187 64–128 8 16–64 2–8 0.03–0.06
S. haemolyticus IE246 0.5–2 2–4 0.25–2 0.25–1 0.03–0.12
S. haemolyticus M176 32–128 2–4 16–128 2–8 0.03–0.06
CFZ, cefazolin; VAN, vancomycin; DCX, dicloxacillin; TET, tetracycline;
RIF, rifampicin.
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were added. Growth was allowed to occur over 6 h. A control was
obtained by adding TSB with 0.25% of glucose but without any anti-
biotic to the biofilm cultures. At 2 h time intervals, the planktonic
cells of four random wells were removed carefully and the biofilm
was washed twice with 200 mL of 0.9% NaCl. The four wells were
thoroughly scraped until >93% (–5%) of the biofilm was removed
(as determined by crystal violet spectrophotometric readings)21 and
resuspended in 1 mL of 0.9% NaCl, followed by centrifugation for
8 min at 9000g. The pellet was resuspended in 0.9% NaCl and washed
twice, followed by 20 s of sonication at 20 W. The viable cells were
determined by performing 10-fold serial dilutions of this suspension
and plating 100 mL of the dilutions in triplicate on TSA plates that were
then incubated for 20 h at 37C. This experiment was repeated three
times, with individual samples evaluated in triplicate.
Antibiotic susceptibility of planktonic cultures
assessed by XTT
The XTT colorimetric method was applied to determine antibiotic
susceptibility as described previously,22 with some modifications.
Briefly, after 3 h of exposure of 200 mL of a bacterial suspension to
the antibiotics, cells were washed twice with 200 mL of 0.9% NaCl
and transferred to individual wells of a 96-well microtitre plate. Then,
50 mL of a solution containing 200 mg of XTT ({2,3-bis(2-methoxy-
4-nitro-5-sulfophenyl)-5-[(phenyalamino)carbonyl]-2H-tetrazolium
hydroxide}) (Sigma, MO, USA) per L and 20 mg PMS (phenazine
methosulphate) (Sigma, MO, USA) per L was added to each well. The
microtitre plates were incubated for 3 h at 37C in the dark. After that,
200 mL of the liquid medium in each well was transferred to a 1.5 mL
tube and centrifuged for 5 min at 9500g. For the spectrophotometric
readings, 100 mL of the supernatant was transferred to a new microtitre
plate, and the absorbance was measured at 490 nm. A control was
obtained with a cell suspension not exposed to the antibiotics. All
samples were conducted in quadruplicate, and each experiment was
repeated three times.
Antibiotic susceptibility of biofilms assessed by XTT
The XTT colorimetric method was applied to determine the antibiotic
susceptibility as described previously,22 with some modifications.
Briefly, biofilms exposed to the antibiotics were gently washed
twice with 200 mL of 0.9% NaCl, then 250 mL of a solution containing
200 mg XTT/L and 20 mg PMS/L was added to each well. Microtitre
plates were incubated for 3 h at 37C in the dark. Then, 200 mL from
each well was transferred to a 1.5 mL tube, and centrifuged for 5 min at
9500g. For the spectrophotometric readings, 100 mL of the supernatant
was transferred to a new microtitre plate, and the absorbance was
measured at 490 nm. Controls were biofilms not exposed to the anti-
biotics. All samples were carried out in quadruplicate, and the experi-
ment was repeated three times.
Statistical analysis
All the assays were compared using one-way analysis of variance
(ANOVA) by applying the Levene’s test of homogeneity of variances,
and the Tukey multiple-comparisons test, or by paired samples t-tests,
using the Statistical Package for the Social Sciences software. Differ-
ences were considered significant when non-overlapping confidence
levels of ‡95% were achieved.
Results
Kinetics study
Figure 1 presents the time–kill curves for the tested antibiotics
(see Table 1) at the PS concentration against both planktonic
and biofilm cells of S. epidermidis 9142. The growth profiles
of S. epidermidis 9142 cells not exposed to antibiotics in
planktonic cultures versus biofilm cultures were significantly dif-
ferent (P < 0.05, ANOVA and Tukey multiple-comparisons test).
Non-antibiotic-treated planktonic cells had significant growth
over 6 h, whereas only a slight increase in cfu/mL was noted in
cells growing in biofilms. All three cell-wall synthesis inhibitors
(cefazolin, vancomycin, and dicloxacillin) were highly effective
against planktonic cells, showing nearly a 1 log decrease in viable
cells in the first hour, and a near 3 log difference after 6 h of
exposure. Tetracycline was the least effective antibiotic on plank-
tonic cells, whereas rifampicin exhibited intermediate efficacy.
The activity of cell-wall synthesis inhibitors on cells growing in
biofilms was markedly less than their activity on planktonic cells:
the decrease in viable bacterial cells was <0.5 log even after 6 h
of exposure to these antibiotics. It is interesting to note that in
contrast to planktonic cells, tetracycline and rifampicin were the
most effective antibiotics in terms of reducing viability of cells in
biofilms.
Antibiotic susceptibility assessed by cfu plating
Figure 2 shows the mean reduction in bacterial cell viability for
six different CoNS strains after exposure of planktonic cultures or
cells in biofilms to antibiotics. As expected, for all S. epidermidis
and S. haemolyticus strains, planktonic cells were more susceptible
to all cell wall synthesis inhibitors used, compared with cells in
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Figure 1. Control growth curves (Ct) and time–kill plots of the effect of
cefazolin (CFZ), vancomycin (VAN), dicloxacillin (DCX), tetracycline
(TET) and rifampicin (RIF) on S. epidermidis 9142 planktonic cells (a) and
biofilm (b). Points represent means and error bars the SEM.
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biofilms. The differences in cellular survival detected between
planktonic cells and biofilm cells with protein and RNA synthesis
inhibitors were lower. In fact, for 50% of the strains there was
no significant difference in the susceptibility of planktonic
cells and biofilms to rifampicin (P > 0.05, paired t-test). The
same was observed for S. epidermidis with tetracycline but not
for S. haemolyticus since cells in biofilms or planktonic cultures
had significantly different susceptibilities.
When analysing the average differences in susceptibilities
between planktonic cells and biofilms, for each antibiotic, a ratio
can be calculated between the susceptibility of planktonic cells
and biofilm cells: 7.0 for cefazolin, 6.4 for vancomycin, 5.6 for
dicloxacillin, 2.0 for tetracycline and 1.6 for rifampicin. This shows
that rifampicin and tetracycline are less affected by the biofilm
phenotype, since the ratios of their activities are close to 1 when
comparing effects in planktonic and biofilm cells. In contrast,
all three cell wall inhibitors were highly affected by the biofilm
phenotype, as demonstrated by the high ratios of the activities.
Antibiotic susceptibility assessed by XTT
Figure 3 presents the mean reduction in metabolic activity after
exposure of planktonic cultures and cells in biofilms to antibiotics,
as measured by the decrease in metabolic activity using the XTT
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Figure 2. Mean fold reduction of cellular viability after 3 h of exposure to antibiotics. The y-axis indicates the difference in the log10 cfu/mL between strains without
antibiotic (controls) and strains treated with antibiotics (CFZ, cefazolin; VAN, vancomycin; DCX, dicloxacillin; TET, tetracycline; RIF, rifampicin), in planktonic
cells (grey bars) and biofilm (white bars).Different bars represent different strains, from left to right: S. epidermidis9142, IE186,M129,M187,S. haemolyticus IE246
and M176. *Indicates values that are not significantly different (P > 0.05, paired t-test).
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Figure 3. Mean reduction of cellular activity,measured byXTT, after 3 h of exposure to the antibiotics, expressed as the difference in absorbance readings at 490 nm
between controls without antibiotic and antibiotic treated strains (CFZ, cefazolin; VAN, vancomycin; DCX, dicloxacillin; TET, tetracycline; RIF, rifampicin) permg
of antibiotic used (D/PS), in planktonic cells (grey bars) and biofilm (white bars). Different bars represent different strains, from left to right: S. epidermidis 9142,
IE186, M129, M187, S. haemolyticus IE246 and M176. *Indicates values that are not significantly different (P > 0.05, paired t-test).
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reagent. The findings were very similar to the results obtained
by measuring the decrease in viability by cfu plating: the major
reductions in metabolic activity were primarily found with
planktonic cells, and the differences between cells in biofilms
and planktonic cells were greater for cell wall synthesis inhibitors.
Discussion
Antibiotic resistance is a serious problem encountered with many
human pathogens,23 and is particularly notable with S. epidermidis,
since many clinical isolates of this organism are resistant to up
to eight different antibiotics.24 Adding to this problem is the fact
that the major virulence factor of S. epidermidis and other CoNS
is biofilm formation25 and that cells in biofilms are normally more
resistant to antibiotics than planktonic cells,6 making drug resist-
ance in a CoNS infection an even more serious problem.
A number of assays have been developed to quantify the level of
susceptibility of cells in biofilms, but such assays do not provide
a fair comparison with the standard MIC assay for planktonic
bacteria.16,26,27 This is because NCCLS standards stipulate the use
of low inocula of the planktonic bacteria,28 whereas bacteria are at
a high cell density in established biofilms. This difference affects
antibiotic susceptibility assays in a number of ways. First, certain
antibiotics such as vancomycin exhibit a cell density-dependent
effect and are much less effective against high bacterial inocula.
Second, most antibiotic susceptibility assays for cells in biofilms
measure the minimum biofilm eradication concentration (MBEC)
rather than the MIC.16 It has been established that in any bacterial
population, be it planktonic or sessile cells in biofilms, there exists
a certain percentage of persister cells, which are extremely tolerant
to antibiotics.15,29 For this reason it takes a high concentration of a
given antibiotic to completely eradicate even a planktonic popu-
lation of bacteria. Overall, comparing the MICs of planktonic bac-
teria with the MBEC of biofilm bacteria may result in exaggerated
differences between the susceptibility levels. Indeed, while com-
parisons between MICs for planktonic cells and MBECs for cells
in biofilms suggests there may be a 1000-fold difference in the
susceptibility of the biofilm cells to certain antibiotics, we found in
this study that the killing efficacy of achievable peak serum con-
centrations of cefazolin, vancomycin, dicloxacillin, tetracycline
and rifampicin was less than 10-fold higher against S. epidermidis
cells in biofilms. This decrease in efficacy is still quite significant,
however, and could account for frequent therapeutic failure of
these drugs against biofilm infections.
A critical first step in understanding mechanisms of antibiotic
resistance of cells in biofilms is to have a method to accurately
determine the level of resistance relative to planktonic populations.
Besides determination of viable cells by classic cfu plating, we
evaluated the effects of antibiotics on metabolic activity by col-
orimetrically measuring XTT reduction.30 This method has started
to become widely used and several comparisons with NCCLS
standard susceptibility tests have already demonstrated its reliab-
ility.22,31 One of the major advantages of this method is the short
time necessary to obtain results. Measuring antibiotic susceptibil-
ities of cells in biofilms can be laborious and the application of a
reliable and rapid method is desirable in a clinical laboratory. Kuhn
et al. described the lower sensitivity as one disadvantage of the
XTT method.32 Our results also demonstrated that the cfu plating
method has a higher sensitivity, when compared with XTT.
The assay described here provides amore consistent comparison
between the antibiotic susceptibilities of planktonic versus biofilm
populations. Furthermore, since the antibiotics were used at the PS
concentration, the relative differences in the effects of antibiotics
on planktonic versus biofilm cells can be considered to have
potential clinical relevance. The present results demonstrate that
rifampicin was the most effective antibiotic against S. epidermidis
or S. haemolyticus cells in biofilms, as assessed by both cfu plating
and XTT measurements. As the pathogenesis of CoNS is often
dependent upon colonization of abiotic, implanted surfaces
and subsequent biofilm formation, it is of utmost importance to
assess the susceptibility of cells in biofilms to antibiotics rather
than the susceptibility of planktonic cells. Many clinical practices
still rely on MIC determinations performed with microbial sus-
pensions;33–35 however, as the present results demonstrate, the
susceptibility levels of planktonic cells do not reflect the corres-
pondent susceptibility of the cells in biofilms.
The differences in cfu following antibiotic treatment demon-
strated that, on average, for all strains tested, the susceptibility
to tetracycline and rifampicin was less affected by the biofilm
phenotype. In fact, for some strains there was no significant
difference in the cfu achieved comparing planktonic cells and
biofilm cells in regard to their susceptibility to antibiotics (the
ratio was almost 1).
Low growth rates have been considered as an antibiotic
resistance mechanism that has been observed in Escherichia coli
biofilms.36 In the present analysis, growth rates of cells in bio-
films were lower than that of planktonic cells (Figure 1), which
could partially explain the higher resistance of biofilms to anti-
biotics, particularly for cell wall synthesis inhibitors whose
efficiency is very much dependent of the growth rate of the
cells. However, RNA synthesis inhibitors are also dependent
on the growth rate of the cell and our results showed that both
planktonic cells and cells in biofilms were comparably susceptible
to these agents. It has also been suggested that the biofilm matrix
itself could pose a barrier to the penetration of the antibiotics.8–10
However, other studies indicate that diffusion through the biofilm
matrix is roughly equivalent to water 37 and our results indicate that
antibiotics with the same mechanism of action but having different
molecular weights did not differ in their efficacy against cells in
biofilms.
Our results demonstrated that antibiotics that target cell wall
synthesis have a reduced activity in biofilms, independent of the
size of the antibiotic molecule, but antibiotics that target RNA and
protein synthesis have similar activities on planktonic cells as they
do on cells in biofilms, suggesting that the phenotypic resistance of
cells in biofilms to antibiotics is affected primarily by the mech-
anism of action of the antibiotic. Several different resistance mech-
anisms in biofilms have been suggested, and although each one
can partially explain some cases of antibiotic resistance of cells in
biofilms, an overall understanding of antibiotic resistance of this
phenotype is still yet to be elucidated. Considering that biofilm
formation is one of the major virulence factors involved in CoNS
infections,1 susceptibility testing of CoNS should not rely on MIC
determinations. XTT activity measurements could provide a quick
and reliable methodology to assess the susceptibility of CoNS cells
growing in biofilms to antibiotics.
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